CHR-6494 TFA NEW
| Price | $58 | $130 | $211 |
| Package | 1mg | 5mg | 10mg |
| Supply Ability: | 10g |
| Update Time: | 2026-04-21 |
Product Details
| Product Name: CHR-6494 TFA | CAS No.: 1458630-17-5 |
| Purity: 99.50% | Supply Ability: 10g |
| Release date: 2026/04/21 |
Product Introduction
Bioactivity
| Name | CHR-6494 TFA |
| Description | CHR-6494 TFA is a potent haspin inhibitor with an IC50 of 2 nM, inhibiting histone H3T3 phosphorylation. It induces apoptosis in cancer cells, including melanoma and breast cancer, and is useful for cancer research. |
| In vitro | Administration of CHR-6494 (TFA; 0-10-5?nM; 72 hours) dose-dependently inhibits the growth of cancer cells, such as HCT-116, HeLa, MDA-MB-231, and Wi-38 cells, with an IC50s of 500?nM, 473?nM, 752?nM and 1059 nM, respectively[1]. Administration of CHR-6494 (TFA; 500 nM) produces a mitotic catastrophe with abnormal morphology of the mitotic spindle and centrosome amplification, and upregulates the spindle assembly checkpoint protein BUB1 and the marker of mitotic arrest cyclin B1[1]. |
| In vivo | Administration of CHR-6494 (TFA; 50?mg/kg; i.p. in two cycles of five consecutive days for 15 days) inhibits the growth of tumor and no obvious body weight change is observed in nude mice bearing HCT-116 human colorectal cancer cells[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 55 mg/mL (135.35 mM), Sonication is recommended. |
| Keywords | NRAS mutant melanoma cells | mitotic catastrophe | mice | Inhibitor | inhibit | Haspin Kinase | CHR-6494 TFA | CHR6494 TFA | CHR-6494 | CHR6494 | CHR 6494 TFA | CHR 6494 | cancer cells | BRAFV600E mutant melanoma cells | apoptosis |
| Inhibitors Related | LDN-209929 dihydrochloride | Haspin-IN-2 | INE963 | HSK205 | Haspin-IN-3 | AZ1495 | Haspin-IN-1 | Haspin-IN-4 | MELK-8a | CHR-6494 | LDN-192960 hydrochloride | LDN-192960 |
| Related Compound Libraries | Bioactive Compound Library | Kinase Inhibitor Library | Bioactive Compounds Library Max | Fluorochemical Library | Anti-Cancer Compound Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $5.00 |
VIP2Y
|
Hebei Jiafan Trading Company Limited
|
2026-06-30 | |
| $61.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-06-02 | |
| $1980.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-05-11 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY